Dual-action mRNA vaccine takes aim at aggressive skin cancer

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. The findings are published in Cell Reports.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup